Jennifer Michaelson Cullinan Oncology, Inc. (CGEM) insider trading activity

Jennifer Michaelson is Chief Scientific Officer of Cullinan Oncology, Inc.. Currently has a direct ownership of 99,760 shares of CGEM, which is worth approximately $1.22 Million. The most recent transaction as insider was on Dec 18, 2024, when has been sold 4,693 shares (Common Stock) at a price of $11.41 per share, resulting in proceeds of $53,547. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 99.8K

13.96% 3M change

13.9% 12M change

Total Value Held $1.22 Million

Jennifer Michaelson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 18 2024	SELL Open market or private sale	$53,547 $11.41 p/Share	4,693 Reduced 4.49%	99,760 Common Stock
Dec 12 2024	SELL Open market or private sale	$43,682 $12.52 p/Share	3,489 Reduced 3.23%	104,453 Common Stock
Nov 05 2024	SELL Open market or private sale	$125,120 $15.64 p/Share	8,000 Reduced 6.9%	107,942 Common Stock
Sep 05 2024	SELL Open market or private sale	$144,720 $18.09 p/Share	8,000 Reduced 6.45%	115,942 Common Stock
Jul 05 2024	SELL Open market or private sale	$130,639 $16.33 p/Share	8,000 Reduced 6.06%	123,942 Common Stock
Jul 01 2024	BUY Grant, award, or other acquisition	$21,240 $9.0 p/Share	2,360 Added 1.76%	131,942 Common Stock
May 07 2024	SELL Open market or private sale	$168,516 $30.06 p/Share	5,606 Reduced 4.15%	129,582 Common Stock
May 07 2024	BUY Exercise of conversion of derivative security	$24,105 $4.3 p/Share	5,606 Added 3.98%	135,188 Common Stock
May 06 2024	SELL Open market or private sale	$1,634,440 $28.18 p/Share	58,000 Reduced 30.92%	129,582 Common Stock
May 06 2024	BUY Exercise of conversion of derivative security	$215,000 $4.3 p/Share	50,000 Added 21.05%	187,582 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	50,000 Added 26.66%	137,582 Common Stock
Dec 21 2023	SELL Open market or private sale	$9,732 $8.5 p/Share	1,145 Reduced 1.29%	87,582 Common Stock
Dec 18 2023	SELL Open market or private sale	$1,956 $8.22 p/Share	238 Reduced 0.27%	88,727 Common Stock
Dec 12 2023	SELL Open market or private sale	$8,341 $7.81 p/Share	1,068 Reduced 1.19%	88,965 Common Stock
Jun 20 2023	SELL Open market or private sale	$3,079 $12.94 p/Share	238 Reduced 0.26%	90,033 Common Stock
Jun 12 2023	SELL Open market or private sale	$2,307 $13.11 p/Share	176 Reduced 0.19%	90,271 Common Stock
Jun 07 2023	SELL Open market or private sale	$1,240 $12.4 p/Share	100 Reduced 0.11%	90,447 Common Stock
Jun 07 2023	BUY Exercise of conversion of derivative security	$430 $4.3 p/Share	100 Added 0.11%	90,547 Common Stock
Jun 06 2023	SELL Open market or private sale	$146,489 $12.31 p/Share	11,900 Reduced 11.63%	90,447 Common Stock
Jun 06 2023	BUY Exercise of conversion of derivative security	$51,170 $4.3 p/Share	11,900 Added 10.42%	102,347 Common Stock
May 18 2023	SELL Open market or private sale	$2,093 $8.76 p/Share	239 Reduced 0.26%	90,447 Common Stock
May 12 2023	SELL Open market or private sale	$1,694 $8.78 p/Share	193 Reduced 0.21%	90,686 Common Stock
Apr 18 2023	SELL Open market or private sale	$2,548 $10.71 p/Share	238 Reduced 0.26%	90,879 Common Stock
Apr 12 2023	SELL Open market or private sale	$1,798 $10.22 p/Share	176 Reduced 0.19%	91,117 Common Stock
Mar 20 2023	SELL Open market or private sale	$2,694 $11.32 p/Share	238 Reduced 0.26%	91,293 Common Stock

Jennifer Michaelson

Chief Scientific Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Value

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cullinan Oncology, Inc.

Track Activities on CGEM

Account